Kyle Piskel Adaptive Biotechnologies Corp (ADPT) insider trading activity
Kyle Piskel is Chief Financial Officer of Adaptive Biotechnologies Corp. Currently has a direct ownership of 154,330 shares of ADPT, which is worth approximately $986,168. The most recent transaction as insider was on Nov 18, 2024, when has been sold 248 shares (Common Stock) at a price of $4.98 per share, resulting in proceeds of $1,235. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
154K
0.16%
3M change
76.77%
12M change
Total Value Held
$986,168
KYLE PISKEL Transaction History
KP
Kyle Piskel
Chief Financial Officer
Seattle, WA